Andlauer Healthcare Group Inc.
AND.TO
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -4.07% | -3.17% | -3.26% | 0.13% | 0.72% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -4.07% | -3.17% | -3.26% | 0.13% | 0.72% |
| Cost of Revenue | -5.35% | -3.76% | -2.55% | -1.64% | 0.20% |
| Gross Profit | -1.52% | -1.96% | -4.60% | 3.71% | 1.79% |
| SG&A Expenses | 17.49% | 11.29% | -3.33% | 3.10% | 10.21% |
| Depreciation & Amortization | 1.10% | -8.12% | -1.13% | -0.96% | 2.74% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.20% | -2.95% | -2.44% | -1.10% | 1.46% |
| Operating Income | -15.81% | -4.63% | -7.33% | 7.77% | -3.65% |
| Income Before Tax | -15.23% | 17.37% | -9.02% | 4.64% | -2.26% |
| Income Tax Expenses | -14.64% | -9.89% | -11.10% | 5.17% | -3.67% |
| Earnings from Continuing Operations | -15.44% | 27.32% | -8.22% | 4.44% | -1.73% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.44% | 27.32% | -8.22% | 4.44% | -1.73% |
| EBIT | -15.81% | -4.63% | -7.33% | 7.77% | -3.65% |
| EBITDA | -38.56% | -34.69% | 19.63% | 2.62% | -0.92% |
| EPS Basic | -11.23% | 34.28% | -3.54% | 11.03% | 0.21% |
| Normalized Basic EPS | -11.61% | -0.66% | -4.39% | 11.26% | -0.33% |
| EPS Diluted | -11.52% | 36.90% | -2.47% | 12.00% | 0.84% |
| Normalized Diluted EPS | -11.71% | -0.40% | -3.46% | 11.68% | -0.04% |
| Average Basic Shares Outstanding | -4.76% | -5.19% | -4.86% | -5.95% | -1.93% |
| Average Diluted Shares Outstanding | -4.65% | -5.38% | -5.78% | -6.28% | -2.22% |
| Dividend Per Share | 18.60% | 12.67% | 18.73% | 20.27% | 22.65% |
| Payout Ratio | 0.39% | -0.16% | 0.23% | 0.08% | 0.18% |